NR3C2 and acute kidney injury: AKI and hyperkaliemia are common causes of temporary or definitive down titration or discontinuation of mineralocorticoid receptor antagonists and RAAS blockers, while these two therapeutic classes are prognostic in HF and after AKI [34,35].